Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
14
NCT01701934
Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease
Phase: Phase 2
Role: Collaborator
Start: Feb 28, 2013
Completion: Dec 31, 2014